The new report by Expert Market Research titled, ‘Global Inflammatory Bowel Disease Treatment Market Share’, gives an in-depth analysis of the global inflammatory bowel disease treatment market, assessing the market based on its segments like drug, disease, end-use, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/inflammatory-bowel-disease-treatment-market/requestsample
The key highlights of the report include:
Market Overview (2023-2031)
- Historical Market Size (2022): USD 18.24 Billion
- Forecast CAGR (2023-2031): 4.70%
- Forecast Market Size (2028): USD 24.02 Billion
The global inflammatory bowel disease treatment market is expanding due to factors such as the rising prevalence of Crohn’s disease and ulcerative colitis, increased government funding for inflammatory bowel disease studies, and medical technology advancements.
In addition, the growing popularity of pre-biotic and pro-biotic food products, as well as a rising number of drugs in clinical trials, are likely to contribute to market growth during the assessment period.
Industry Definition and Major Segments
IBD refers to a category of inflammatory disorders that affect the colon and small intestine. The two most common forms of inflammatory bowel disease are Crohn’s disease and ulcerative colitis. The treatment of the disease is known as inflammatory bowel disease treatment.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/inflammatory-bowel-disease-treatment-market
Based on drug, the market can be divided into:
- Aminosalicylates
- Antibiotics
- Corticosteroids
- Immunomodulators
- Biologics
- Others
Based on disease, the market is divided into:
- Ulcerative Colitis
- Crohn’s Disease
- Indeterminate Colitis
The market can be categorised based on end-use into:
- Fertility Centres
- Hospitals and Surgical Clinics
- Research Institutes
- Cryobanks
Regionally, the industry is classified into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Trends
Rising demand for effective treatment has been driving the growth of the industry. Janssen Biotech Inc. and Protagonist Therapeutics Inc. signed a strategic agreement in 2017 to produce, manufacture, and market PTG-200, an oral IL 23 receptor for the treatment of inflammatory bowel disease. In another case, the European Union granted Pfizer Inc. marketing authorization for XELJANZ in 2018 for the treatment of moderate to serious ulcerative colitis.
Key Market Players
The major players in the market are Abbott Laboratories, Biocon Ltd., F. Hoffmann-La Roche Ag, Johnson & Johnson, Mylan Pharmaceuticals Ltd., Novartis Ag, Pfizer Inc., Quest Medical Inc., Sanofi S.A., and Takeda Pharmaceutical Company Ltd.
The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Read More Reports:
Clutch Disc Market: https://www.expertmarketresearch.com/reports/clutch-disc-market
CMOS X-Ray Detectors Market: https://www.expertmarketresearch.com/reports/cmos-x-ray-detectors-market
Vertical Farming Market: https://www.expertmarketresearch.com/reports/vertical-farming-market
Cyber Security Market: https://www.expertmarketresearch.com/reports/cyber-security-market
Crude Oil Market: https://www.expertmarketresearch.com/reports/crude-oil-market
About Us:
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Media Contact
Company Name: Claight Corporation
Contact Person:-Mayra Anderson, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com
